chr6-152148298-G-C
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_182961.4(SYNE1):c.24723C>G(p.His8241Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00055 in 1,613,898 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_182961.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SYNE1 | ENST00000367255.10 | c.24723C>G | p.His8241Gln | missense_variant | Exon 137 of 146 | 1 | NM_182961.4 | ENSP00000356224.5 | ||
SYNE1 | ENST00000354674.5 | c.1188C>G | p.His396Gln | missense_variant | Exon 8 of 18 | 5 | NM_001347702.2 | ENSP00000346701.4 |
Frequencies
GnomAD3 genomes AF: 0.000467 AC: 71AN: 152164Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000583 AC: 146AN: 250554Hom.: 1 AF XY: 0.000598 AC XY: 81AN XY: 135382
GnomAD4 exome AF: 0.000559 AC: 817AN: 1461616Hom.: 1 Cov.: 32 AF XY: 0.000530 AC XY: 385AN XY: 727086
GnomAD4 genome AF: 0.000466 AC: 71AN: 152282Hom.: 1 Cov.: 32 AF XY: 0.000349 AC XY: 26AN XY: 74466
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
- -
The p.His8170Gln variant (rs141586001) has not been reported in the medical literature, gene specific variation databases, nor has it been previously identified by our laboratory. This variant is listed in the Genome Aggregation Database (gnomAD) with a population frequency of 0.1 percent in the European Non-Finnish population (identified on 145 out of 125,962 chromosomes), and has been reported to the ClinVar database with conflicting interpretations. The histidine at position 8170 is weakly conserved and computational analyses of the p.His8170Gln variant on protein structure and function indicate a neutral effect (SIFT: tolerated, MutationTaster: polymorphism, PolyPhen-2: benign). Altogether, there is not enough evidence to classify the p.His8170Gln variant with certainty. -
- -
Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant Uncertain:1
This sequence change replaces histidine, which is basic and polar, with glutamine, which is neutral and polar, at codon 8170 of the SYNE1 protein (p.His8170Gln). This variant is present in population databases (rs141586001, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with SYNE1-related conditions. ClinVar contains an entry for this variant (Variation ID: 194306). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
SYNE1-related disorder Uncertain:1
The SYNE1 c.24510C>G variant is predicted to result in the amino acid substitution p.His8170Gln. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.12% of alleles in individuals of European (Non-Finnish) descent in gnomAD, including one homozygous individual (http://gnomad.broadinstitute.org/variant/6-152469433-G-C). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
not specified Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Intellectual disability Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at